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BACKGROUND  
• Following COVID-19, the ECC will begin to use 
ETCO2 in intubated patients to measure 





DISCUSSION• Prior to the start of this project in September 2019, 
the Emergency Care Center (ECC) staff did not 
include capnography monitoring during moderate 
sedation procedures. Due to the high risk for 
negative respiratory outcomes, a need to update 
clinical practice to the most current 
recommendations was determined. 
• Utilizing ETCO2 during moderation sedation 
procedures can identify deterioration faster and 
allow RNs to intervene quicker.
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• Design - Implementation of an evidence-based 
clinical practice guideline
• Sample – ECC RNs / EHR documentation of 
patients receiving moderate sedation
• Setting – Emergency Care Center
• Procedure: 
• Education to RNs – staff meetings, individual 
and group updates with PowerPoints, and 
emails on the use, setup, indications for ETCO2
• Incorporated education into the annual self-
learning module for moderate sedation
• Monthly audits of EHR for identified clinical 
outcomes:
• Use of ETCO2
• VS during moderate sedation
• Time to baseline
• Presence of adverse events
• 23% of all audited charts between 9/19 - 7/20 had 
ETCO2 documented per policy.
• 0% use in 11/19 & 12/19, this prompted re-
education and spot training in 1/20 for an 
increase to 53% use between 2/20 - 7/20.
• 98% of audited records had a normal pulse 
oximetry reading; for those that had ETCO2
documented, 47% had values greater than 10% 
outside of the normal limits.
• RNs noted and appropriately responded to 
abnormal ETCO2 (with normal pulse oximetry).  
Patient condition stabilized with return to 
baseline.
• Short acting analgesia and sedation medications are 
used during many procedures in the Emergency 
Department (ED).
• Patients require close monitoring for abnormal vital 
signs and other adverse occurrences, such as 
respiratory depression and apnea.
• Use of ETCO2 is recommended by the Emergency 
Nurses Association (ENA). 
• The ENA evidence-based Clinical Practice Guideline 
(2015) determined that capnography during 
moderate sedation detects respiratory depression 
and apnea faster than vital signs, pulse oximetry, 
and clinical assessment during short acting 
analgesia and sedation.
• The opportunity exists to improve the use of 
ETCO2 for moderate sedation.  Further education 
and timely reinforcement will continue.
• Patients who predominately mouth breath result 
in the inability of nasal sensor to pick up ETCO2 
which may provide inaccurate readings.  
CONCLUSION
• The use of ETCO2 in theory and in practice 
allows detection of respiratory depression 
faster than pulse oximetry, allowing timely RN 
intervention with excellent patient outcomes.
